Pharma business info

After two earlier rejections in 2010, Amylin Pharmaceutical’s diabetes medication Bydureon lastly bagged the Food and Drug Administration’s (FDA) nod on January 27.

Spectrum Pharmaceuticals has inked a deal to get hold of licensing rights to sell ZEVALIN (ibritumomab tiuxetan) jab for intravenous usage outside of the United States from Bayer Healthcare.

Fitch Ratings said that the 2012 viewpoint for the Indian pharmaceutical sector is static. The agency projects credit profiles to stay stable given that long-standing profits and profitability outlooks stay intact with moderate capital expenditure.

The family of a late Hyde Park female has taken legal action against a pharmaceutical firm, claiming it made a defective pain-relief patch, which resulted in her demise.